Clinical trials have evaluated testosterone (in men), estrogen (in women), ghrelin, vitamin D, eicosapentaenoic acid, angiotensin-converting enzyme inhibitors, dehydroepiandrosterone, and growth hormone's ability to prevent and/or treatment sarcopenia (24). The gene discussed is GHRL; the disease is sarcopenia.